Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

被引:0
作者
Thierry Poynard
Pascal Lebray
Patrick Ingiliz
Anne Varaut
Brigitte Varsat
Yen Ngo
Pascal Norha
Mona Munteanu
Fabienne Drane
Djamila Messous
Françoise Imbert Bismut
Jean Pierre Carrau
Julien Massard
Vlad Ratziu
Jean Pierre Giordanella
机构
[1] Université Pierre et Marie Curie,APHP
[2] Caisse Primaire Assurance Maladie,UPMC
[3] Biopredictive,Liver Center, Assistance Publique Hôpitaux de Paris
[4] Université Pierre et Marie Curie,Biochemistry Unit, Assistance Publique Hôpitaux de Paris
来源
BMC Gastroenterology | / 10卷
关键词
Liver Fibrosis; Nonalcoholic Fatty Liver Disease; Advanced Fibrosis; Selective Screening; Selective Strategy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 277 条
[1]  
Hakama M(2008)Cancer screening: evidence and practice in Europe 2008 Eur J Cancer 44 1404-13
[2]  
Coleman MP(2003)A comparison of fibrosis progression in chronic liver diseases J Hepatol 38 257-65
[3]  
Alexe DM(2008)Diagnosis and quantitation of fibrosis Gastroenterology 134 1670-81
[4]  
Auvinen A(2008)Methodological aspects for the interpretation of liver fibrosis non-invasive biomarkers: a 2008 update Gastroenterol Clin Biol 32 8-21
[5]  
Poynard T(2008)FibroTest-ActiTest as a non-invasive marker of liver ?brosis Gastroenterol Clin Biol 32 22-38
[6]  
Mathurin P(2008)An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (Fibrotest-Actitest) and viral load PlosOne 3 e2573-105
[7]  
Lai CL(2009)Diagnostic and prognostic values of non-invasive biomarkers of fibrosis in patients with alcoholic liver disease Hepatology 49 97-74
[8]  
Guyader D(2008)Performance of transient elastography for the staging of liver fibrosis: a meta-analysis Gastroenterology 134 960-18
[9]  
Poupon R(2008)Concordance in a world without a gold standard: A new non-invasive methodology for improving accuracy of fibrosis markers PlosOne 3 e3857-31
[10]  
Tainturier MH(2007)Screening for liver disease using non-invasive biomarkers (FibroTest-SteatoTest-NashTest-FibroSURE) in patients with hyperlipidaemia Aliment Pharmacol Ther 25 207-8